According to FutureWise analysis the market for antiarrhythmic drugs in 2023 was US$ 1.16 billion, and is expected to reach US$ 1.81 billion by 2031 at a CAGR of 5.7%. Antiarrhythmic drugs are essential medications designed to treat and prevent abnormal heart rhythms, known as arrhythmias, which arise due to disruptions in the heart's electrical system. These arrhythmias may present as...

According to FutureWise analysis the market for anti-venom in 2023 was US$ 0.65 billion, and is expected to reach US$ 1.32 billion by 2031 at a CAGR of 9.1%. Anti-venom, also referred to as antivenin, is a therapeutic treatment designed to counteract the effects of venom from specific animals when administered promptly after a snakebite or other venomous encounter. This treatment relies...

According to FutureWise analysis the market for anthrax treatment in 2023 was US$ 0.6 billion, and is expected to reach US$ 1.08 billion by 2031 at a CAGR of 7.60%. Anthrax primarily affects farm animals but can also infect humans through contact with contaminated animals or their products, as well as through heroin injection. Individuals working in laboratories or those at risk of...

The anterior chamber of the eye refers to the triangular space located between the back surface of the cornea and the front surface of the iris, including part of the ciliary body. Typically, the anterior chamber measures between 2.5 mm and 3.5 mm in depth and contains approximately 0.25 ml of aqueous humor. This fluid is vital for maintaining the structural integrity of the eye and providing...

Antenatal screening, frequently referred to as prenatal screening, encompasses a variety of medical tests and evaluations conducted during pregnancy to monitor the health status of both the mother and the fetus. The primary objective of antenatal screening is to identify potential health risks, conditions, or abnormalities that may impact the pregnancy, the fetus, or the mother's well-being....

According to FutureWise analysis the market for Antacids in 2023 was US$ 7.59 billion, and is expected to reach US$ 10.89 billion by 2031 at a CAGR of 4.60%. Antacids are over-the-counter medications designed to alleviate symptoms of heartburn and indigestion by neutralizing excess stomach acid. They are particularly effective in providing rapid relief from discomfort associated with acid...

According to FutureWise analysis the market for anoscope is expected to register a CAGR of 6.12% from 2023-2031. Anoscopy is a medical procedure used to inspect the anal canal and rectum with a specialized instrument called an anoscope. This anoscope is a slender tube, similar in width to a finger, and is typically around 5 inches long, made from either plastic or metal. During the procedure,...

According to FutureWise analysis the market for ankylosing spondylitis in 2023 was US$ 5.82 billion, and is expected to reach US$ 11.2 billion by 2031 at a CAGR of 8.52%. Ankylosing spondylitis is a type of arthritis characterized by inflammation of the joints and ligaments in the spine, as well as peripheral joints such as those in the hips, knees, and ankles. This inflammation can lead...

According to Futurewise analysis the Animal Genetics Market was US$ 5.9 billion in 2023, and is projected to expand at a CAGR of 6.7% over the forecast period of 2023-2031. Animal genetics is a specialized field within veterinary medicine that focuses on the study of genes and their impact on living organisms. The genetic information encoded in an organism’s DNA acts as a biological...

According to FutureWise analysis the market for Angiotensin Converting Enzyme (ACE) Inhibitors in 2023 was US$ 3.63 billion, and is expected to reach US$ 5.42 billion by 2031 at a CAGR of 5.10%. Angiotensin-Converting Enzyme (ACE) inhibitors are a class of medications designed to relax veins and arteries, effectively lowering blood pressure. They function by inhibiting an enzyme that plays a...